HHS launch­es $500M uni­ver­sal vac­cine plat­form as RFK Jr. shakes up US vac­cine pol­i­cy

4 weeks ago
Pharma
Coronavirus

Am­gen says FDA hold is lift­ed on its Phase 1 obe­si­ty can­di­date as Mar­i­Tide en­ters Phase 3

4 weeks ago
Pharma

FDA ad­comms slat­ed to re­view da­ta on long-term opi­oid use, over­dos­es

4 weeks ago
Pharma
FDA+

RFK Jr. claims place­bo-con­trolled vac­cine tri­als are 'rad­i­cal de­par­ture' from past. Ex­perts dis­agree

4 weeks ago
FDA+

Bris­tol My­ers to close cell ther­a­py site in Illi­nois as part of on­go­ing cost cuts

4 weeks ago
People
Cell/Gene Tx

Lil­ly CEO Ricks urges Trump to drop drug tar­iff plan

4 weeks ago
Pharma
Manufacturing

Mod­er­na, fac­ing rev­enue miss­es and po­lit­i­cal head­winds, dis­ap­points Wall Street

4 weeks ago
R&D
Pharma

Zoc­doc launch­es an AI voice as­sis­tant

4 weeks ago
Health Tech

Fu­ture­House de­buts AI sci­ence agents, invit­ing skep­ti­cal sci­en­tists to try for free

4 weeks ago
AI

CROs raise the alarm as clients de­lay R&D plans over fund­ing, tar­iff wor­ries

4 weeks ago
R&D
Outsourcing

US drug­mak­ers in­creas­ing­ly look abroad for clin­i­cal tri­als as con­fi­dence in FDA wa­vers

4 weeks ago
Pharma
In Focus

FDA ap­proves Sat­suma's mi­graine nasal spray af­ter re­jec­tion in 2024

4 weeks ago
Pharma
FDA+

Arv­inas ends plans for two Phase 3 breast can­cer tri­als; Phath­om makes cuts

4 weeks ago
News Briefing

Af­ter hunt for al­ter­na­tives, Kro­nos Bio se­lects Tang Cap­i­tal's Con­cen­tra for a deal

4 weeks ago
Deals

Bio­gen says Leqem­bi sales are im­prov­ing slow­ly fol­low­ing lack­lus­ter launch

4 weeks ago
Pharma

Lil­ly meets sales ex­pec­ta­tions, but No­vo gains on PBM win

4 weeks ago
Pharma

Ex­clu­sive: Ex-Cal­i­co sci­en­tist launch­es State­ly Bio with new way to study cells

4 weeks ago
Financing
AI

Am­i­cus grabs Dimer­ix’s rare kid­ney dis­ease drug for $30M up­front

4 weeks ago
Deals
Pharma

Mod­er­na ex­pands ef­fort to rein in costs in an ‘un­cer­tain en­vi­ron­ment’

4 weeks ago
R&D
Pharma

Teladoc buys vir­tu­al ther­a­py start­up Up­Lift for $30M

4 weeks ago
Deals
Health Tech

BeiGene scores a win from US Patent Of­fice in spat over Brukin­sa

4 weeks ago
Pharma
Law

Ex­its con­tin­ue at FDA, as more staff in drug of­fice fol­low fired col­leagues out the door

4 weeks ago
People
FDA+

Re­gen­eron los­es bid to fend off DOJ fight over Eylea Medicare pay­ments

4 weeks ago
Pharma
Law

Sci­en­tists alarmed about fu­ture of can­cer re­search; TIG­IT, CAR-NK and more from #AACR25

4 weeks ago
R&D
First page Previous page 78910111213 Next page Last page
A service from the Financial Times